Net profit of Biogen Pharmachem Industries reported to Rs 0.74 crore in the quarter ended March 2024 as against net loss of Rs 0.20 crore during the previous quarter ended March 2023. There were no Sales reported in the quarter ended March 2024 and during the previous quarter ended March 2023.For the full year,net profit rose 319.57% to Rs 1.93 crore in the year ended March 2024 as against Rs 0.46 crore during the previous year ended March 2023. There were no Sales reported in the year ended March 2024 and during the previous year ended March 2023.Powered by Capital Market - Live News

Biogen Pharmachem Industries will hold a meeting of the Board of Directors of the Company on 25 May 2024Powered by Capital Market - Live News

Net profit of Biogen Pharmachem Industries declined 80.00% to Rs 0.06 crore in the quarter ended December 2023 as against Rs 0.30 crore during the previous quarter ended December 2022. There were no Sales reported in the quarter ended December 2023 and during the previous quarter ended December 2022.Powered by Capital Market - Live News

Biogen Pharmachem Industries will hold a meeting of the Board of Directors of the Company on 22 January 2024.Powered by Capital Market - Live News

Biogen Pharmachem Industries announced that an Extra Ordinary General Meeting (EGM) of the Company will be held on 1 February 2024 .Powered by Capital Market - Live News